Antacid Market Size, Share and Growth Analysis by 2027
The global antacid market was valued at US$ 8,547.97 million in 2019 and is speculated to generate US$ 11,666.83 million by 2027, expanding at a record annual growth rate of 4.0% during 2020–2027.
Antacid hails from the class of drugs neutralizing the stomach acid. It effectively cures heartburn, indigestion, acidity, and an upset stomach. Antacids are available in the form of tablets, capsules, liquid, and powder for oral consumption. Aluminum hydroxide, magnesium carbonate, magnesium trisilicate, magnesium hydroxide, calcium carbonate, and sodium bicarbonate are among the major antacids available. The constituents of antacid help in controlling stomach acid pH.
Antacid products are distributed through channels such as hospital, retail, and online pharmacy. They are actually over-the-counter (OTC) drugs, also known as non-prescription medicines, which are safe and effective to consume by following the directions on the label or as directed by concerned healthcare professionals.
Antacid Market - COVID-19 Impact and Analysis
Antacids Retained the Demand Due to Acidity Being One of the Side Effects of COVID-19 Medications
The sales of essential over-the-counter (OTC) drugs such as antacids were affected due to COVID-19 global pandemic. Pharmaceutical companies switched to non-physical marketing campaigns and shifted to online sales processes. To prevent the outrun of non-prescription drugs such as antacids, the US enacted Coronavirus Aid Relief and Economic Security (CARES) act—a landmark legislation providing financial relief to workers, healthcare professionals, and small enterprises affected by the pandemic. Europe witnessed a surging demand for OTC drugs during pandemic. Several countries curbed the sales and purchase of non-prescription drugs to maintain supply and counteracted stockpiling or panic buying.
A little different and positive picture was observed in the Asia Pacific antacid market during the pandemic phase. India, one of the largest pharmaceutical manufacturing hubs, contributed to the majority shares of generic supplies and branded drugs worldwide with full operational capacity of manufacturers. APAC practiced self-medication during COVID-19 pandemic due to enhanced patient awareness. Acidity, being the common side effect associated with COVID-19 medication, fuelled the demand for antacids. Disruption in the global trade and reduced imports caused a shortage of medical supplies resulting in price growth in the Middle East and South & Central America. Irrespective of different prices and supply modes, the overall demand for antacids was leveraged globally during the COVID-19 pandemic.
Antacid Market Future Trends
Several manufacturers operating in the antacid market emphasize developing and launching new products to widen their geographic reach and capacity to cater to the large consumer pool. GSK Consumer Healthcare, a leading global consumer healthcare company, launched ENO Cooling, a product for immediate acidity relief and instant cooling sensation. In May 2017, Piramal Enterprises, headquartered in Mumbai, launched a paan (betel-leaf)-flavored variant of antacid called Polycrol, which not only relieves acidity but also offers a pleasant taste. Dr. Reddy’s Laboratories, an Indian multinational pharmaceutical, in October 2020, launched OTC generic drug, Famotidine tablet, in the American market to treat gastroesophageal reflux disease. Moreover, Sun Pharmaceuticals Ltd launched its first consumer healthcare product, Pepmelt, a mouth-melt granular form of drug.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Antacid Market: Strategic Insights
Market Size Value in US$ 8,547.97 Million in 2019 Market Size Value by US$ 11,666.83 Million by 2027 Growth rate CAGR of 4.0% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Antacid Market: Strategic Insights
| Market Size Value in | US$ 8,547.97 Million in 2019 |
| Market Size Value by | US$ 11,666.83 Million by 2027 |
| Growth rate | CAGR of 4.0% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Antacid Market Drivers
Growing Prevalence of Gastroesophageal Reflux Disease (GERD)
Gastroesophageal reflux disease, a digestive disorder, affects the muscle ring between esophagus and stomach. According to the statistics of the report ‘update on the epidemiology of GERD: a systematic review’ published in 2014, the percentage prevalence of this disorder ranged 18.1–27.8% in North America, 2.5–7.8% in East Asia, and 8.8–25.9% in Europe. Besides, the National GI Survey conducted in 2015, stated that 18% of the 71,000 people tested were reported to develop episodes of GERD twice a week and 31% of patients exhibited the instances at least once a week. Additionally, it was observed that the condition is more prevalent in women. Almost 35% of the GERD patients used medications, while 55% preferred proton-pump inhibitors as medication therapy.
Increasing Cases of Obesity
Obesity has been a major risk factor triggering GERD. Excess belly fat causes pressure on the stomach and the hiatal hernia leads to the acid backflow. Also, the increased relaxation of lower esophageal sphincter (LES) in obese people causes higher acid reflux. Most overweight or people with high BMI (25–30 kg/m2) suffer from acidity or GERD. According to the WHO, over 1.9 billion adults were found overweight in 2016, of which around 650 million were obese. The prevalence of obesity was 42.4% in the US during 2017–2018. Obesity has been a major health concern in China as the instances increased over three times from 2004 to 2014. Apart from GERD, obese body condition houses many other disorders that require OTC drugs such as antacids for treatment, thus favoring the growth of global antacid market.
Antacid Market Restraints
Lack of Awareness Associated with Gastrointestinal (GI) Disorders in Low-Income Economies
Most people refrain from early-stage disease reporting due to behavioural and psychosocial aspects. Also, the low awareness and adoption of screening methods tend to deviate from the treatment, thereby jeopardizing the degree of health. Despite the significant development, many GI disorders are still poorly interpreted and require safe, novel, and effective therapies. These disorders are more prevalent in developing economies due to changing environmental factors, dietary habits, and excess use of antibiotics. Common GI diseases such as GERD, ulcerative colitis, and Crohn’s disease still require optimal screening and diagnosis in low-income countries. Several digestive disorders are subject to extensive and expensive diagnostic tests such as endoscopy, ultrasound, CAT scan, or MRI. However, the lack of infrastructure and dearth of skilled professionals hamper the screening of digestive disorders.
Antacid Market Segmentation By Dosage Form
Easy Storage and Suitable Dosage Amount to Surge the Segmental Reign
Based on dosage form, the global antacid market is segmented into tablets, liquids, and others. Among these, the tablet segment dominated the market in 2019, followed by the liquid segment occupying second-highest market share but growing with the highest CAGR over the forecast period. Various types of antacid tablets available in the market are chewable gummy, normal tablets, and water-soluble ones. These tablets are easy to store and deliver an adequate amount of dosage as compared to other forms.
Liquid dosage forms are useful for the patients having trouble in swallowing the solid pills, as the absorption rate of liquid medication is quicker than the solid dosage. Also, it is largely recommended for children and aging population owing to its flavored and palatable taste. Major market players such as Procter & Gamble, Pfizer, GSK Group, and others offer liquid antacids to propel the segmental growth.
Antacid Market Segmentation By Drug Class
Advanced Drug Delivery Systems Coupled with Growing GI Diseases Fuel the Segment’s Dominance
According to the drug class, the antacid market comprises proton pump inhibitors (PPIs), H2 antagonists, and acid neutralizers, of which the proton pump inhibitors segment occupied the largest revenue share in 2019. These inhibitors work on the cells that line the stomach and cease the acid production. They majorly include lansoprazole, esomeprazole, pantoprazole, and others. They prevent ulcers in the duodenum and stomach and also inhibit the damage caused to the lower esophagus by acid reflux. Growth of inhibitor’s segment has been attributed to new drug delivery systems, prevalence of peptic ulcers, and other gastrointestinal diseases.
The H2 antagonist segment held the second-largest market share in 2019 with a significant CAGR. They are also called H2 blockers that obstruct the action of histamine to curb acid production in the stomach. These antagonists are well absorbed in the body and relieve the problems such as heartburn, gastritis, inflamed stomach, and peptic ulcers. In some cases, patients are prescribed H2 antagonists if they encounter any side effect with the consumption of proton pump inhibitors. Moreover, the increasing prevalence of GERD and stress-induced ulcers are likely to foster the segmental growth.
Antacid Market Regional Insights
Geographically, the global antacid market is segmented into North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South & Central America (SCAM).
North America dominated the global antacid market in 2019 and is projected to retain its dominance throughout the forecast period. The regional antacid market domain is split into the US, Canada, and Mexico, with the US at the forefront. Increasing cases of GI diseases due to changed lifestyle, government aid to mitigate GI disorders, advanced healthcare infrastructure, expanding pharmaceutical industry, reimbursement coverage, and the presence of prominent market players are among the conducive parameters bolstering the growth of the North America antacid market.
The Asia Pacific antacid market is anticipated to surge at the highest CAGR over the forecast period. The region comprises major economies such as China, Japan, India, Australia, and South Korea, of which China, Japan, and India accounted for the concrete market share. The rapidly growing antacid market in Asia Pacific is accustomed to changing lifestyle & food consumption patterns, expanding pharmaceutical industry, rising demand for OTC drugs, growing sales of antacids, and strategic developments by local players.
Antacid Market Report Scope
Key Market Players:
- Bayer AG (Germany)
- GlaxoSmithKline plc (UK)
- Takeda Pharmaceutical Company Limited (Japan)
- Sun Pharmaceutical Industries Ltd (India)
- Sanofi (France)
- Boehringer Ingelheim International GmbH (Germany)
- Dr. Reddy's Laboratories (India)
- Pfizer Inc (US)
- Reckitt Benckiser Group Plc (UK)
- Procter & Gamble (US)
Key Developments in Antacid Market:
June 2018:
GlaxoSmithKline plc acquired about 36.5% stake from Novartis for an estimated value of US$ 13 billion. The acquisition helped the company strengthen its consumer healthcare business worldwide.August 2020:
Takeda Pharmaceutical Company Limited declared to divest Takeda Consumer Healthcare Company Limited, a wholly owned subsidiary of Takeda operating in Japan, to the Blackstone Group Inc.May 2017:
Pfizer Limited (India) acquired AstraZeneca AB’s brand, Neksium, in India. The deal was valued at around Rs. 75 crores. Neksium is an antacid containing Esomeprazole as an API.
Report Coverage
The global antacid market research report delivers a detailed analysis of the OTC drugs in terms of market size, share, trends, and forecasts. The report provides crisp and precise insights of drivers, restraints, opportunities, segments, and industrial landscape. The impact of COVID-19 is elaborated with the aftermath observed in global and regional markets. The segmental analysis features the dominant markets with respective revenue shares and annual growth rates.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Dosage Form ; Drug Class ; Distribution Channel and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The antacid market majorly consists of the players such as Sanofi, GlaxoSmithKline plc, Bayer AG, Takeda Pharmaceutical Company Limited, Sun Pharmaceuticals Ltd, Boehringer Ingelheim International Gmbh, Dr. Reddy’s Laboratories Ltd., Pfizer, Inc, Reckitt Benckiser Group Plc., and Procter And Gamble amongst others.
The factors that are driving growth of the market are increasing prevalence of GERD, and rising prevalence of obesity. However, low awareness associated with gastrointestinal disorders in low-income economies is restricting the market growth.
The class of drugs that neutralize the acid in the stomach are known as antacids. It is used to treat conditions like heartburn, indigestion, acidity and an upset stomach. These drugs are available over the counter and are usually consumed by mouth. They are available in tablets, capsules, liquid and powder form.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Antacid Market – By Dosage Form
1.3.2 Antacid Market – By Drug Class
1.3.3 Antacid Market – By Distribution Channel
1.3.4 Global Antacid Market – By Geography
2. Antacid Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antacids– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Antacid Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Gastroesophageal Reflux Disease (GERD)
5.1.2 Increase in Prevalence of Obesity
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Research Activities and Research Funds on GI Disorders
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Antacid Market – Global Analysis
6.1 Global Antacid Market Revenue Forecast And Analysis
6.2 Global Antacid Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Antacid Market Analysis – By Dosage Form
7.1 Overview
7.2 Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
7.3 Tablet
7.3.1 Overview
7.3.2 Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Liquid
7.4.1 Overview
7.4.2 Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8. Antacid Market Analysis – By Drug Class
8.1 Overview
8.2 Antacid Market Revenue Share, by Drug Class (2019 and 2027)
8.3 Proton Pump Inhibitors
8.3.1 Overview
8.3.2 Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.4 H? Antagonist
8.4.1 Overview
8.4.2 H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Acid Neutralizers
8.5.1 Overview
8.5.2 Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.3 Magaldrate
8.5.3.1 Overview
8.5.3.2 Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.4 Sucralfate
8.5.4.1 Overview
8.5.4.2 Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
8.5.5 Others
8.5.5.1 Overview
8.5.5.2 Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9. Antacid Market Analysis – By Distribution Channel
9.1 Overview
9.2 Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
10. Antacid Market – Geographic Analysis
10.1 North America: Antacid Market
10.1.1 Overview
10.1.2 North America: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.4 North America: Antacid Market, by Drug Class, 2018–2027 (USD Million)
10.1.4.1 North America: Acid Neutralizers Market, by Type, 2018–2027 (USD Million)
10.1.5 North America: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.6 North America: Antacid Market, by Country, 2019 & 2027 (%)
10.1.7 US: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.7.3 US: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.7.3.1 US: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.7.4 US: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.8 Canada: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.8.3 Canada: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.8.3.1 Canada: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.8.4 Canada: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.1.9 Mexico: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.1.9.3 Mexico: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.1.9.3.1 Mexico: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.1.9.4 Mexico: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2 Europe: Antacid Market
10.2.1 Overview
10.2.2 Europe: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.4 Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.4.1 Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.5 Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2.6 Europe: Antacid Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.7.3 Germany: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.7.3.1 Germany: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.7.4 Germany: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2.8 UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.8.3 UK: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.8.3.1 UK: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.8.4 UK: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2.9 France: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.9.3 France: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.9.3.1 France: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.9.4 France: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2.10 Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.10.3 Spain: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.10.3.1 Spain: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.10.4 Spain: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2.11 Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.11.3 Italy: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.11.3.1 Italy: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.11.4 Italy: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.2.12 Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)
10.2.12.3 Rest of Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)
10.2.12.3.1 Rest of Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)
10.2.12.4 Rest of Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)
10.3 Asia-Pacific: Antacid Market
10.3.1 Overview
10.3.2 Asia-Pacific: Antacid Market,- Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia-Pacific: Antacid Market, by Dosage Form– Revenue and Forecast to 2027 (USD Million)
10.3.4 Asia-Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.4.1 Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.5 Asia-Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.6 Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
10.3.7 China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.7.3.1 China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.7.4 China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.8 Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.8.3.1 Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.8.4 Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.9 India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.9.5 India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.10 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.10.3.1 South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.10.4 South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.11 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Australia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.11.3.1 Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.3.12 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.12.1 Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.3.12.2 Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.3.12.3 Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.3.12.4 Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.3.12.5 Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Antacid Market
10.4.1 Overview
10.4.2 Middle East & Africa: Antacid Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Antacid Market, by Dosage Form– Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.4.4.1 Middle East & Africa: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.4.7.3.1 Saudi Arabia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.8 UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.4.8.5 UAE: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.4.9.5 South Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.4.10 Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.4.10.4 Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
10.4.10.5 Rest of Middle East and Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Antacid Market
10.5.1 Overview
10.5.2 South and Central America: Antacid Market - Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.5.4.1 South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Antacid Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.5.7.3.1 Brazil: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.5.8.3.1 Argentina: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.5.9 Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America: Antacid Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
10.5.9.3 Rest of South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
10.5.9.3.1 Rest of South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.5.9.4 Rest of South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Antacid Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Antacid Market– Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Bayer AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sun Pharmaceutical Industries Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Boehringer Ingelheim International GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Dr. Reddy's Laboratories
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Pfizer Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 roducts and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Reckitt Benckiser Group Plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Procter & Gamble
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. US Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 6. US Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 7. US Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 8. US Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Antacid Market, by Dosage Form– Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 25. UK Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 26. UK Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 27. UK Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 28. UK Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 29. France Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 30. France Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 31. France Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 32. France Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 41. Rest of Europe Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 42. Rest of Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 45. Asia-Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 46. Asia-Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 47. Asia-Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 48. Asia-Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 49. China: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 50. China: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 51. China: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 52. China: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 53. Japan: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 54. Japan: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 55. Japan: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 56. Japan: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 57. India: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 58. India: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 59. India: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 60. India: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 61. South Korea: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 62. South Korea: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 63. South Korea: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 65. Australia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 66. Australia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 67. Australia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 68. Australia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Asia Pacific: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 70. Rest of Asia Pacific: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 71. Rest of Asia Pacific: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 72. Rest of Asia Pacific: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 73. Middle East & Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 74. Middle East & Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East & Africa: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 76. Middle East & Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 77. Saudi Arabia: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 78. Saudi Arabia: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 80. Saudi Arabia: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 81. UAE: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 82. UAE: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 83. UAE: Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 84. UAE: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 85. South Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 86. South Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 87. South Africa Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 88. South Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 89. Rest of Middle East and Africa: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 90. Rest of Middle East and Africa: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 91. Rest of Middle East and Africa Antacid Market, by Acid Neutralizers – Revenue and Forecast to 2027 (USD Million)
Table 92. Rest of Middle East and Africa: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 93. South and Central America: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 94. South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 95. South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 96. South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 97. Brazil: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 98. Brazil: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 99. Brazil: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 100. Brazil: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 101. Argentina: Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)
Table 102. Argentina: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 103. Argentina: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 104. Argentina: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 105. Rest of South and Central America: Antacid Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)
Table 106. Rest of South and Central America: Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)
Table 107. Rest of South and Central America: Acid Neutralizers Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 108. Rest of South and Central America: Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms, Antacid Market
LIST OF FIGURES
Figure 1. Antacid Market Segmentation
Figure 2. Antacid Market – By Geography
Figure 3. Antacid Market Overview
Figure 4. Liquid to Witness Rapid Growth of Antacid Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Antacid Market, by Geography (US$ Million)
Figure 7. Global Antacid Market – Leading Country Markets (US$ Million)
Figure 8. Global Antacid Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Antacid Market Impact Analysis of Drivers and Restraints
Figure 15. Global Antacid Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Antacid Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Antacid Market
Figure 18. Antacid Market Revenue Share, by Dosage Form (2019 and 2027)
Figure 19. Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Antacid Market Revenue Share, by Drug Class (2019 and 2027)
Figure 23. Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. H? Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 30. Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. North America Antacid Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Antacid Market, by Country, 2019 & 2027 (%)
Figure 36. US: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 40. Europe Antacid Market Revenue and Forecast to 2027 (USD Million)
Figure 41. Europe: Antacid Market, by Country, 2019 & 2027 (%)
Figure 42. Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. France: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia-Pacific: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 49. Asia-Pacific: Antacid Market, Revenue and Forecast to 2027 (USD Million)
Figure 50. Asia-Pacific: Antacid Market, by Country, 2019 & 2027 (%)
Figure 51. China: Antacid Market, – Revenue and Forecast to 2027 (USD Million)
Figure 52. Japan Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. India: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. South Korea: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Australia: Antacid – Revenue and Forecast to 2027 (USD Million)
Figure 56. Rest of Asia Pacific: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Antacid Market, by Key Country – Revenue (2019) (USD Million)
Figure 58. Middle East & Africa Antacid Market –Revenue and Forecast to 2027 (USD Million)
Figure 59. Middle East & Africa: Antacid Market, by Country, 2019 & 2027 (%)
Figure 60. Saudi Arabia: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. UAE: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. South Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. Rest of Middle East and Africa: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. South and Central America: Antacid Market , by Key Country – Revenue (2019) (USD Million)
Figure 65. South and Central America: Antacid Market, Revenue and Forecast to 2027 (USD Million)
Figure 66. South and Central America: Antacid Market, by Country, 2019 & 2027 (%)
Figure 67. Brazil: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 68. Argentina: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. Rest of South and Central America: Antacid Market – Revenue and Forecast to 2027 (USD Million)
Figure 70. Impact of COVID-19 Pandemic on Antacid Market in North American Countries
Figure 71. Impact of COVID-19 Pandemic on Antacid Market in European Countries
Figure 72. Impact of COVID-19 Pandemic on Antacid Market in Asia Pacific Countries
Figure 73. Impact of COVID-19 Pandemic on Antacid Market in Rest of the World
Figure 74. Growth Strategies Done by the Companies in the Market
The List of Companies - Antacid Market
- Bayer AG
- GlaxoSmithKline plc.
- Takeda Pharmaceutical Company Limited
- Sun Pharmaceutical Industries Ltd
- Sanofi
- Boehringer Ingelheim International GmbH
- Dr. Reddy's Laboratories
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Procter & Gamble
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Antacid Market
Nov 2020
Infectious Disease Therapeutics Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti Bacterial, Anti-Fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Nov 2020
Clinic Casting and Splinting Products Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product [Casting (Casts, Tapes, Cutters, and Casting Accessories) and Splinting (Splints and Splinting Accessories)], Application (Acute Fractures or Sprains, Tendon and Ligament Injuries, and Others), Material (Plaster of Paris, Fiberglass, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2020
Myopia Treatment Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (High Myopia, Degenerative Myopia, Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Ortho-K, Contact Lenses, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers), and Geography
Nov 2020
Epilepsy Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First-Generation Drugs, Second-Generation Drugs, and Third-Generation Drugs), Age Group (Adults and Children), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Nov 2020
Vaccine Adjuvants Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography
Nov 2020
Human Vaccine Adjuvants Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography
Nov 2020
Epilepsy Drugs Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (First-Generation Anti-Epileptics, Second Generation Anti-Epileptics, Third Generation Anti-Epileptics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Geography
Nov 2020
Specialty Hospitals Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Specialty Type (Pediatric Hospitals, Obstetrics-Gynecology Hospitals, ENT Hospitals, Oncology Hospitals, Rehabilitation Hospitals, Orthopedic Hospitals, Neurology Hospitals, Cardiology Hospitals, IVF Hospitals and Others), Service Type (Outpatient and Inpatient), Hospital Type (Public Hospitals and Private Hospitals), and Geography (North America, Europe, Asia Pacific, and Middle East & Africa)
Get Free Sample For